The center was specifically designed with cutting-edge equipment and improvements to advance the R&D process, including automated technologies that reduce the time for preparing, producing and refining pilot drug formulations. In addition, all of the equipment in the facility is aligned with the production equipment in Abbott's commercial manufacturing sites, which will allow for rapid scale-up of production as drug compounds move toward late-stage clinical trials and market availability for patients.
"We considered several locations for the new formulation center, but
decided to strategically place the building in the midst of our other
Abbott Park R&D facilities to provide easy access for our scientists,
pharmacists and engineers," said Leonard.
Fast Facts for Abbott's New Formulation Development Center
-- Location: Abbott Park, Ill.
-- Size and structure: Two-story, 64,000-square-foot facility features a
flexible design with modular walls and ceilings that will allow for
rapid future expansion
-- Key Current Formulation Programs: Currently developing oral
formulations (capsule and tablet) for clinical studies involving new
compounds to treat cancer, hepatitis, pain and other areas
-- Investment: $53 million
-- Facility Initiated/Completed: Groundbreaking in June 2005; Completed in
-- Personnel: Seventeen dedicated onsite employees; more than 40
additional staff regularly work in the facility
Abbott is a global, broad-based health care company devoted to the
discovery, development, manufacture and marketing of pharmaceuticals and
medical products, including nutritionals, devices and diagnostics. The
company employs more than 68,000 people and markets
Copyright©2008 PR Newswire.
All rights reserved